Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Tau Isoforms and Proteolysis for Production of Toxic Tau Fragments in Neurodegeneration
Ben Boyarko, Vivian Hook
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
Madhurima Chatterjee, Selcuk Özdemir, Christian Fritz, et al.
Nature Medicine (2024) Vol. 30, Iss. 6, pp. 1771-1783
Open Access | Times Cited: 66
Frontotemporal Dementia, Where Do We Stand? A Narrative Review
Annibale Antonioni, Emanuela Maria Raho, Piervito Lopriore, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11732-11732
Open Access | Times Cited: 50
Disentangling tau: One protein, many therapeutic approaches
Courtney Lane‐Donovan, Adam L. Boxer
Neurotherapeutics (2024) Vol. 21, Iss. 2, pp. e00321-e00321
Open Access | Times Cited: 18
The role of microbiome-host interactions in the development of Alzheimer´s disease
Christian Weber, Alexander Dilthey, Patrick Finzer
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 26
Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer’s disease tauopathies
Anton Lindberg, Emily Murrell, Junchao Tong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Caspase-cleaved tau is senescence-associated and induces a toxic gain of function by putting a brake on axonal transport
Christian Conze, Marina Rierola, Nataliya I. Trushina, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 7, pp. 3010-3023
Open Access | Times Cited: 33
The Role of Tau Proteoforms in Health and Disease
Zuha Waheed, Jawaria Choudhary, Faria Hasan Jatala, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 9, pp. 5155-5166
Closed Access | Times Cited: 19
Natural polyphenol: Their pathogenesis-targeting therapeutic potential in Alzheimer's disease
Chengu Niu, Miaoxian Dong, Yingcai Niu
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116359-116359
Closed Access | Times Cited: 8
Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry
Michael J. Ellis, Christiana Lekka, Katie Holden, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 8
Dysregulation of Neuropeptide and Tau Peptide Signatures in Human Alzheimer’s Disease Brain
Sonia Podvin, Zhenze Jiang, Ben Boyarko, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 13, pp. 1992-2005
Open Access | Times Cited: 27
Aging, NRF2, and TAU: A Perfect Match for Neurodegeneration?
Mirjam Brackhan, Marina Arribas-Blázquez, Isabel Lastres‐Becker
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1564-1564
Open Access | Times Cited: 13
The Need for Biomarkers in the ALS–FTD Spectrum: A Clinical Point of View on the Role of Proteomics
Francesca Vignaroli, Angelica Mele, Giacomo Tondo, et al.
Proteomes (2023) Vol. 11, Iss. 1, pp. 1-1
Open Access | Times Cited: 12
Exploring the significance of caspase-cleaved tau in tauopathies and as a complementary pathology to phospho-tau in Alzheimer’s disease: implications for biomarker development and therapeutic targeting
Liara Rizzi, Lea T. Grinberg
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Validation of Tau Antibodies for Use in Western Blotting and Immunohistochemistry
Michael J. Ellis, Christiana Lekka, Hanna Tulmin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 10
Tau truncation in the pathogenesis of Alzheimer’s disease: a narrative review
Dandan Chu, Xingyue Yang, Jing Wang, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 6, pp. 1221-1232
Open Access | Times Cited: 10
Proteomic Subtyping of Alzheimer's Disease CSF links Blood-Brain Barrier Dysfunction to Reduced levels of Tau and Synaptic Biomarkers
Madison C. Bangs, Joshna Gadhavi, Kathleen Carter, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Differential Regulation of Tau Exon 2 and 10 Isoforms in Huntington’s Disease Brain
Séréna Petry, Behnaz Nateghi, Rémi Keraudren, et al.
Neuroscience (2022) Vol. 518, pp. 54-63
Closed Access | Times Cited: 15
A novel transgenic mouse line with hippocampus-dominant and inducible expression of truncated human tau
Yang Gao, Yuying Wang, Huiyang Lei, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 9
24-Hydroxycholesterol Induces Tau Proteasome-Dependent Degradation via the SIRT1/PGC1α/Nrf2 Pathway: A Potential Mechanism to Counteract Alzheimer’s Disease
Gabriella Testa, Serena Giannelli, Barbara Sottero, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 631-631
Open Access | Times Cited: 8
An emerging role for the gut microbiome in tauopathy
Yiyang Zhu, Wade Self, David M. Holtzman
Neurotherapeutics (2024) Vol. 21, Iss. 6, pp. e00423-e00423
Open Access | Times Cited: 3
Recent advances in nanoenzymes for Alzheimer's disease treatment
Xiaojun Bi, Ning Cao, Jingteng He
Colloids and Surfaces B Biointerfaces (2024) Vol. 244, pp. 114139-114139
Closed Access | Times Cited: 3
From circadian sleep disruption to Neuroprotection: The potential of VIP/PACAP in Alzheimer’s disease treatment
Artur Galushkin, Illana Gozes
Current Research in Biotechnology (2024) Vol. 8, pp. 100254-100254
Open Access | Times Cited: 3
Accumulation of microtubule-associated protein tau promotes hepatocellular carcinogenesis through inhibiting autophagosome-lysosome fusion
Xuemin Liu, Zhiwei Hao, Huanhuan He, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 3
Recent Advances in Our Molecular and Mechanistic Understanding of Misfolded Cellular Proteins in Alzheimer’s Disease (AD) and Prion Disease (PrD)
Walter J. Lukiw
Biomolecules (2022) Vol. 12, Iss. 2, pp. 166-166
Open Access | Times Cited: 13
Alzheimer’s disease: an axonal injury disease?
Dan Liang, Zhaohui Zhang
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top